Joe Senn

Joe has experience with nearly all therapeutic modalities, including small molecules, biologics, antisense, gene editing, and mRNA therapeutics. He most recently served as the Vice President of Nonclinical Development at Moderna Therapeutics for eight years, where he and his team were responsible for progressing over 40 candidates into the clinic. Prior to Moderna, Dr. Senn served as Site Head for Drug Safety at Takeda Pharmaceuticals, where he oversaw the development of all immunology products across the portfolio.

Dr. Senn received his Ph.D. in Pharmacology and Physiology from the University of Rochester School of Medicine and Dentistry.